Snowden Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.01M | Sell |
49,618
-5,147
| -9% | -$300K | 0.08% | 249 |
|
|
2025
Q4 | $2.95M | Sell |
54,765
-369
| -0.7% | -$17.8K | 0.08% | 252 |
|
|
2025
Q3 | $2.49M | Sell |
55,134
-4,257
| -7% | -$199K | 0.07% | 276 |
|
|
2025
Q2 | $2.75M | Sell |
59,391
-4,502
| -7% | -$221K | 0.08% | 244 |
|
|
2025
Q1 | $3.9M | Sell |
63,893
-5,165
| -7% | -$301K | 0.12% | 180 |
|
|
2024
Q4 | $3.91M | Sell |
69,058
-35,723
| -34% | -$2M | 0.12% | 181 |
|
|
2024
Q3 | $5.42M | Sell |
104,781
-42,924
| -29% | -$2.01M | 0.16% | 148 |
|
|
2024
Q2 | $6.13M | Sell |
147,705
-4,173
| -3% | -$187K | 0.18% | 128 |
|
|
2024
Q1 | $8.24M | Buy |
151,878
+117,023
| +336% | +$5.96M | 0.26% | 90 |
|
|
2023
Q4 | $1.79M | Sell |
34,855
-7,052
| -17% | -$370K | 0.07% | 309 |
|
|
2023
Q3 | $2.43M | Sell |
41,907
-15,968
| -28% | -$978K | 0.1% | 249 |
|
|
2023
Q2 | $3.7M | Buy |
57,875
+10,742
| +23% | +$720K | 0.13% | 204 |
|
|
2023
Q1 | $3.27M | Buy |
47,133
+4,983
| +12% | +$351K | 0.13% | 208 |
|
|
2022
Q4 | $3.03M | Sell |
42,150
-203
| -0.5% | -$15.3K | 0.13% | 203 |
|
|
2022
Q3 | $3.01M | Sell |
42,353
-1,388
| -3% | -$101K | 0.14% | 189 |
|
|
2022
Q2 | $3.37M | Buy |
43,741
+1,351
| +3% | +$103K | 0.15% | 181 |
|
|
2022
Q1 | $3.1M | Buy |
42,390
+22,558
| +114% | +$1.51M | 0.12% | 211 |
|
|
2021
Q4 | $1.24M | Buy |
19,832
+784
| +4% | +$46K | 0.06% | 299 |
|
|
2021
Q3 | $1.13M | Buy |
19,048
+803
| +4% | +$52.9K | 0.06% | 348 |
|
|
2021
Q2 | $1.22M | Buy |
18,245
+1,262
| +7% | +$82.3K | 0.06% | 338 |
|
|
2021
Q1 | $1.07M | Buy |
16,983
+4,976
| +41% | +$310K | 0.06% | 325 |
|
|
2020
Q4 | $745K | Buy |
12,007
+1,394
| +13% | +$85.7K | 0.05% | 357 |
|
|
2020
Q3 | $640K | Sell |
10,613
-1,009
| -9% | -$60.7K | 0.05% | 336 |
|
|
2020
Q2 | $683K | Sell |
11,622
-4,013
| -26% | -$240K | 0.06% | 313 |
|
|
2020
Q1 | $871K | Buy |
15,635
+6,082
| +64% | +$372K | 0.1% | 260 |
|
|
2019
Q4 | $613K | Buy |
9,553
+2,443
| +34% | +$140K | 0.05% | 352 |
|
|
2019
Q3 | $361K | Buy |
7,110
+1,933
| +37% | +$90.8K | 0.04% | 396 |
|
|
2019
Q2 | $235K | Sell |
5,177
-4,680
| -47% | -$218K | 0.02% | 462 |
|
|
2019
Q1 | $470K | Buy |
9,857
+473
| +5% | +$23.6K | 0.05% | 331 |
|
|
2018
Q4 | $488K | Buy |
9,384
+2,898
| +45% | +$156K | 0.06% | 310 |
|
|
2018
Q3 | $403K | Buy |
6,486
+1,513
| +30% | +$89.8K | 0.05% | 347 |
|
|
2018
Q2 | $275K | Buy |
4,973
+572
| +13% | +$30.9K | 0.04% | 379 |
|
|
2018
Q1 | $278K | Buy |
4,401
+1,057
| +32% | +$68K | 0.04% | 333 |
|
|
2017
Q4 | $205K | Buy |
+3,344
| New | +$209K | 0.03% | 386 |
|
|
2017
Q2 | – | Sell |
-3,946
| Closed | -$215K | – | 351 |
|
|
2017
Q1 | $215K | Buy |
+3,946
| New | +$216K | 0.05% | 310 |
|
Other funds holding BMY
VCM
VPM
Snowden Capital Advisors's BMY Position: Q1 2026 in Review
Snowden Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 9.4% in Q1 2026, selling an estimated $300K and leaving 49,618 shares worth $3.01M. The position accounts for 0.08% of the portfolio, ranked #249.
Snowden Capital Advisors first reported a position in BMY in Q1 2017 and has held it in 35 quarters since. The position peaked at $8.24M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Snowden Capital Advisors held 49,618 shares of Bristol-Myers Squibb worth $3.01M as of Q1 2026.
- Snowden Capital Advisors sold 5,147 Bristol-Myers Squibb shares in Q1 2026, an estimated $300K.
- Bristol-Myers Squibb made up 0.08% of Snowden Capital Advisors's portfolio in Q1 2026, its #249 holding.
- Snowden Capital Advisors first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 35 quarters since.
- Snowden Capital Advisors's Bristol-Myers Squibb position peaked at $8.24M in Q1 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.